Results 11 to 20 of about 239,825 (303)

Aspirin: yesterday, today, and tomorrow [PDF]

Pediatria i Medycyna Rodzinna, 2014
Clinical utility of aspirin (acetylsalicylic acid, ASA) is one of the more important issues in the primary and secondary prevention of cardiovascular disease.
Marina Nikołajewna Dołżenko
doaj   +2 more sources

Aspirin overutilization for the primary prevention of cardiovascular disease

Clinical Epidemiology, 2014
Jeffrey J VanWormer,1 Aaron W Miller,2 Shereif H Rezkalla3 1Center for Clinical Epidemiology and Population Health, 2Biomedical Informatics Research Center, Marshfield Clinic Research Foundation, Marshfield, WI, USA; 3Department of Cardiology, Marshfield
VanWormer JJ, Miller AW, Rezkalla SH
doaj   +1 more source

Preeclampsia and aspirin

Obstetrics & Gynecology Science, 2023
Preeclampsia (PE) is a multisystem disorder that is an important cause of maternal and perinatal deaths. Currently, delivery is the only final treatment for PE. This practice is usually accompanied by premature birth, which inevitably increases neonatal morbidities.
Tae Gyu Ahn, Jong Yun Hwang
openaire   +3 more sources

Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease [PDF]

, 2013
Background Aspirin-exacerbated respiratory disease is under-diagnosed and therefore effective and inexpensive therapy with aspirin desensitization is rarely performed.
J. Larco, R. Mirakian, G. Scadding, Miller, B, Darby, Y, Larco, J, Sannah, AA, Scadding, G, Mirakian, R, Y. Darby, Gane, S, B. Miller, S. Gane, A. A. Sannah   +13 more
core   +1 more source

Low-dose aspirin and the severity of ıschemic colitis: A single-center retrospective study

The Turkish Journal of Gastroenterology, 2020
Background/Aims: To evaluate the effect of low-dose aspirin (50-150 mg/d) on the severity of ischaemic colitis. Materials and Methods: A total of 244 patients admitted to our hospital for ischaemic colitis were included in the study between 2013 and ...
Weiming Xiao, Shuai yang Zhou, Keyan Wu, Bin Deng, Dacheng Wu, Yuanzhi Wang, Weijuan Gong, Yanbing Ding, Guotao Lu   +8 more
doaj   +1 more source

Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms

Platelets, 2018
Essential thrombocythemia (ET) and polycythemia vera (PV) are myeloproliferative neoplasms (MPN) with an increased risk of arterial and venous thrombosis.
Andréas Perrier-Cornet, Jean-Christophe Ianotto, Fanny Mingant, Maëla Perrot, Eric Lippert, Hubert Galinat   +5 more
doaj   +1 more source

Aspirin-Induced Ordering and Faster Dynamics of a Cationic Bilayer for Drug Encapsulation

, 2023
The lipid dynamics and phase play decisive roles in drug encapsulation and delivery to the intracellular target. Thus, understanding the dynamic and structural alterations of membranes induced by drugs is essential for targeted delivery.
Harish Srinivasan (408597), Ananya Debnath (1585897), Samapika Sahu (17373222), Sankalp E. Jadhav (17373225), Veerendra K. Sharma (6373340)   +4 more
core   +1 more source

Clinical pictures of phenotypes of intolerance to aspirin and other nonsteroidal anti-inflammatory drugs. Part I

Pediatria i Medycyna Rodzinna, 2014
Clinically, three phenotypes of intolerance to aspirin and other nonsteroidal anti-inflammatory drugs are distinguished: bronchospastic phenotype, urticaria/oedema and chronic hyperplastic eosinophilic sinusitis.
Iwona Grzelewska-Rzymowska, Paweł Górski   +1 more
doaj   +1 more source

Identifying and reducing inappropriate aspirin use in primary care

BMJ Open Quality, 2023
Objective Recent studies have called into question the safety of aspirin use for the primary prevention of atherosclerotic cardiovascular disease, particularly in older adults.
Li Li, Christa Brooker, Rebekah Compton, Terri Babineau, Cornelius Afetorli Normeshie, Sarah Rachel Blackstone   +5 more
doaj   +1 more source

Aspirin in primary prevention of cardiovascular disease and cancer : a systematic review of the balance of evidence from reviews of randomized trials [PDF]

, 2013
Background: Aspirin has been recommended for primary prevention of cardiovascular disease (CVD) and cancer, but overall benefits are unclear. We aimed to use novel methods to re-evaluate the balance of benefits and harms of aspirin using evidence from
Binu Gurung, Gurung, T., Kandala Ngianga-Bakwin, Amy Grove, Gurung, Binu, Morrow, Sarah, Aileen Clarke (470453), Grove, Amy L., Tara Gurung, Kandala, Ngianga-Bakwin, Samantha Johnson (493518), Sutcliffe, P. (Paul), Connock, M., Johnson, Samantha Ann, Binu Gurung (493521), Aileen Clarke, Stranges, Saverio, Martin Connock (159426), Sarah Morrow (493522), Tara Gurung (493516), Sarah Morrow, Kandala Ngianga-Bakwin (493519), Saverio Stranges, Amy Grove (493520), Samantha Johnson, Paul Sutcliffe, Paul Sutcliffe (493515), Karoline Freeman, Martin Connock, Karoline Freeman (493517), Saverio Stranges (73786), Freeman, Karoline, Clarke, Aileen, Clarke Aileen, Freeman Karoline, Connock Martin, Sutcliffe Paul, Ngianga-Bakwin Kandala, Grove Amy, Stranges Saverio, Johnson Samantha, Gurung Tara, Gurung Binu, Morrow Sarah   +43 more
core   +1 more source